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Abstract 
Catheter-associated urinary tract infection (CAUTI) represents one of the most common causes of 
morbidity and mortality. The resistance demonstrated by many microorganisms to conventional 
antibiotic therapies and the in- creasing health-care costs have recently encouraged the deﬁnition of 
alternative preventive strategies, which can have a positive effect in the management of infections. 
Antimicrobial urinary catheters have been developed through the photo-chemical deposition of 
silver coatings on the external and luminal surfaces. The substrates are exposed to ultraviolet 
radiation after impregnation into a silver-based solution, thus inducing the in situ synthesis of silver 
particles. The effect of the surface treatment on the material was investigated through scanning 
electron microscopy (SEM) and silver ion release measurements. The ability of microorganisms 
commonly associated with urinary tract infections was investigated in terms of bacterial viability, 
proliferation and bioﬁlm development, using Escherichia coli, Klebsiella pneumoniae and Proteus 
mirabilis as target organisms. The silver coatings demonstrated good distribution of silver particles 
to the substrate, and proved an effective antibacterial capability in simulated biological conditions. 
The low values of silver ion release demonstrated the optimum adhesion of the coating. The results 
indicated a good potential of silver-based antimicrobial materials for prevention of catheter-
associated urinary tract infection. 
  
 
1. Introduction 
The urinary tract is a sterile environment in healthy people, and rep- resents one of the most 
susceptible sites for bacterial infections in the human body [1]. Urinary tract infections (UTIs) are  
one  of the  most common nosocomial infections, more commonly experienced by women than 
men; and  approximately 80% of UTIs are associated with the presence of an indwelling urinary 
catheter [1–3]. Catheterisation is one of the most common modern medical procedures, where the 
insertion of a urinary catheter bypasses the normal host defences facilitating the entry of pathogens 
into the bladder [2]. The bacterial pathogens most commonly associated with catheter-associated 
urinary tract infections (CAUTIs) are Escherichia coli and Proteus mirabilis [4]. An infection associated 
with Proteus mirabilis frequently leads to blockage of catheters because of biomineralisation and 
formation of a crystalline bioﬁlm through the bioconversion of urinary ammonium and other salts, 
causing obstruction of catheter lumen and kidney infection and septicaemia [4–6]. Klebsiella 
pneumoniae is a gastro-intestinal bacterium and an opportunistic pathogen associated with 
septicaemia, pneumonia, urinary tract infections, and meningitis, and can persist within the urinary 
tract despite appropriate antibiotic treatments [7]. Colonisation by Pseudomonas aeruginosa and 
Candida spp. may also be observed in patients undergoing prolonged catheterizations [4]. After long-
term use, monobacterial bioﬁlm formation has been observed to occur, some- times with multi-drug 
resistant organisms, on many urinary devices [8]. Bacteria  have  been shown to colonise the  
catheter surface and  form  a bioﬁlm on both the internal (intraluminal) and external (extraluminal) 
surfaces of the catheter, suggesting that intervention strategy must ad- dress the issue of reducing 
or preventing bacterial colonisation on both surfaces [9,10]. Prolonged catheterisation is the most 
important risk factor associated with CAUTI, and the formation of bioﬁlm plays a central role in the 
pathogenesis of CAUTIs [11]. Bioﬁlms are heterogeneous structures composed of an accumulation of 
microorganisms and their extracellular products forming a structured community on a surface [12, 
13].  These biological structures are difﬁcult to eradicate because of bioﬁlm-speciﬁc mechanisms of 
tolerance and drug resistance, with the cells and associated materials able to persist on bladder 
epithelium de- spite the removal of the catheters [13, 14].  The increasing reports of antibiotic 
resistance amongst members of the normal human microbiota has been shown to exacerbate the 
recalcitrance of bacterial bioﬁlms on medical devices, limiting available therapeutic options. This is a 
serious medical and public health issue that requires the application of novel approaches to prevent 
bioﬁlm growth on indwelling catheters [15]. An alternative approach is the incorporation of these 
antimicrobial agents into biomaterials used in catheter production, thus developing a catheter 
surface that could inhibit the bacterial growth [16]. The lack of innovative antimicrobials released on 
to the pharmaceutical market in recent years has led to considerable concern from the World Health 
Organization (WHO).  In 2014, the WHO global report on surveillance of antimicrobial resistance 
outlined the possibility of mortality associated to common infections such as those induced by 
Escherichia coli [17]. Progress and implementation in infection control programs are necessary and 
require technical advances in catheter materials for prevention of bioﬁlm formation [18]. A variety 
of strategies, such  as the  replacement of contaminated catheters, novel  materials for catheter 
production  and  surface functionalization with antibacterial agents have  been suggested [4,15], 
including rifampicin, sparﬂoxacin and  triclosan have been proposed for impregnation of urinary 
catheters [4]. Currently, the use of silver in biomedical ﬁeld is increasing because of its broad- 
spectrum antimicrobial activity demonstrated against multi-drug resistant bacteria, fungi and viruses 
[19,20].  At nanometric size, silver is extremely active against microorganisms due to the high 
surface to volume ratio [21]. In this work, silver coatings have been deposited on urinary catheters 
on the inner and outer surfaces through a technique based on the photo-reduction of a silver 
precursor. Scanning electron microscopy (SEM) and silver ion release measurements through 
inductively coupled plasma mass spectrometry (ICP-MS) were performed to investigate the 
properties of the silver coating and to determine the effect of the silver treatment of the material. 
The antimicrobial activity has been evaluated against the most common microorganisms responsible 
for CAUTI through speciﬁc microbiological characterizations aiming to simulate the biological 
environment of the devices. 
 
2. Materials and methods 
2.1. Preparation of samples 
The focus of this study was silicone-coated Foley latex urinary catheters (18 French) designed for 
short-term use only (less than 30 days). They have been deposited with silver coatings by adopting a 
technology based on the photochemical deposition of silver nanoparticles [22]. The method involves 
depositing a silver solution on the surface of the material and inducing the in situ synthesis and 
deposition of silver particles through the UV irradiation of the wet substrate. The silver solution 
adopted for this speciﬁc treatment has been prepared by dissolving silver nitrate (2 w/v%) in 
methanol (98  v/v%) under magnetic stirring at room temperature. Pieces of catheters were 
impregnated with the silver solution through dip coating and exposed to a UV lamp (Jelosil) with an 
emission peak at 365 nm for 10 min. During the UV treatment, the samples were moved to allow the 
irradiation on the inner surface. Next, the catheters were washed carefully in order to remove any 
trace of unreacted silver salt and, then, they have been characterized. 
2.2. SEM-EDX analysis 
Scanning electron microscopy (SEM) (Zeiss EVO) was performed by means of a backscattering 
detector on sections of untreated and silver treated catheters to investigate the presence and 
distribution of silver particles on the outer and luminal surfaces of the device. Additional Energy 
Dispersive X-ray Spectroscopy EDX (Bruker) was carried out to determine the surface composition 
and the presence of silver on both the surfaces of the device. 
  
2.3. Silver ion release 
The release of silver ions from the silver-treated substrates in artiﬁcial urine was analysed through 
ICP-MS (Thermoﬁsher iCAP-Q) at the same time points selected for the microbiological 
characterization. The samples (length 1 cm, average weight 0.2813 g) were incubated at 
37 °C in 3 mL of artiﬁcial urine medium for 1, 3, 7, 10 and 14 days. At each  time  point, the  samples 
of catheters were removed from  the tubes and  the  artiﬁcial urine was  stored at 4 °C for analysis, 
and  were conditioned at room temperature for 1 h. Transition elements calibration standard CCS-6 
and 1, 10, 50 and 100 ppb concentrations were selected for calibration. Artiﬁcial urine was used as 
the analytical matrix (see below for constitution), and 1% HNO3 was used for dilutions. 
 
2.4. Microbiological characterization 
All microbiological media was purchased from Oxoid Ltd. (UK), and all chemicals were purchased 
from Fisher Scientiﬁc (UK). All experiments were performed in triplicate. The bacterial strains used in 
this work were Escherichia coli NCIMB 8545, Klebsiella pneumoniae NCTC 
11228 and Proteus mirabilis NCTC 11938. 
 
2.4.1. Artiﬁcial urine medium 
Artiﬁcial urine (AU) was adapted in-house upon the original work of Stickler et al. [23]. The ﬁnal 
constitution of the stock media was as follows, for 100 mL total volume: 2.3 g sodium disulphate, 
0.65 g magnesium chloride, 4.6 g trisodium citrate, 0.02 g sodium oxalate, 2.8 g potassium 
dihydrogen orthophosphate, 1.6 g potassium chloride, 1 g ammonium chloride, 5 g gelatin, and 1 g 
tryptone soy broth. Reverse osmosis water was used to constitute the medium, which was 
subsequently autoclaved at 121 °C for 15 min.  A solution of urea   and calcium chloride was also 
constituted; comprising 25 g of urea and 0.65 g of calcium chloride in 400 mL of reverse osmosis 
water was also added. This was ﬁlter sterilized using a 0.2 μm syringe ﬁlter in a Class II microbiology 
hood.  Next, 92 mL of the stock medium was added to 8 mL of the urea/calcium chloride solution to 
make the artiﬁcial urine medium. These 100 mL aliquots were prepared aseptically, sealed and 
stored until needed. 
 
2.4.2. Sample preparation 
Samples of untreated and treated Foley catheters were cut in to 1 cm sections using a sterile scalpel 
within a Class II microbiology hood. These samples were sterilized by exposure to UV irradiation at 
250 nm on each side for 30 min, and then sealed in new sterile plastic bags to minimize the risk of 
contamination. Sterility was determined by the inoculation of replicate samples in to tryptone soya 
broth medium. Macroscopic growth was  checked at 24, 48 and  72 h visually,  and  at these time  
points 100  μL aliquots were spread on  to  tryptone soya agar plates (in triplicate) and  incubated for 
72 h at 37 °C, with inspection for colony  growth at 24, 48 and  72 h, respectively. 
 
2.4.3. Bioﬁlm growth 
Bacterial bioﬁlms were cultivated using an adaptation of the method of Cooper and Hanlon [24]. 
Brieﬂy, 1 cm2 catheter sections were immersed in 3 mL of sterile artiﬁcial urine (AU) medium in six-
well plates and inoculated with 100 μL ofa1× 106 CFU/mL of each bacterial strain, respectively. 
These were left to sediment at room temperature for 1 h, after which, the sections were transferred 
into new  six-well plates containing 3 mL phosphate buffered saline (PBS), and placed onto an orbital 
shaker for 15 min at 120 rpm (Stuart Scientiﬁc, UK) so as to dislodge any non-adherent cells. After 
this time, the sections were incubated at 37 °C. At time points 3, 7, 10 and  14 days, the  sections to 
be investigated for bioﬁlm growth were removed and  placed in fresh  six-well plates containing 3 mL 
PBS on an orbital shaker for 15 min at 120 rpm  to remove any non-adherent cells. After this time, 
the samples were placed into 10 mL PBS containing glass balls, and vortexed for 1 min. These 
samples underwent serial dilution, and spread plates were set up, and incubated at 37 °C for 24 h, 
when colony counts were performed. For those samples being incubated for longer time periods, 
the samples were also placed into 3 mL PBS and placed onto an orbital shaker for 15 min. After this 
time, the sections were placed into six-well plates containing 3 mL AU, and incubated at 37 °C. This 
wash step was repeated up until the ﬁnal time point for each of the samples, respectively. 
 
2.4.4. Preparation for scanning electron microscopy 
Replicate samples were set up for each organism at each time point. Samples were ﬁxed using 2.5% 
glutaraldehyde in sodium cacodylate buffer (pH 7.4) for 1 h to remove the natural water. The 
samples were subsequently rinsed three times in cacodylate buffer, and then dehydrated in serially 
increasing concentrations of ethanol (25%, 50%, 
75% and two washes in 97%). Each wash lasted for 30 min, and was con- ducted at room 
temperature and atmospheric pressure. After sputter coating with palladium, the samples were 
examined using a Zeiss EVO SEM (Oxford Instruments, UK). 
 
3. Results 
3.1. Preparation of samples 
The silver deposition technology adopted provided a homogeneous coating characterized by the 
typical darkening, changing to brown, associated to the presence of silver. This proved effective at 
coating all sur- faces, including the luminal surface demonstrating the successful deposition of silver. 
  
3.2. SEM-EDX analysis 
Fig. 1 demonstrates the clearly visible presence of silver particles on all the treated surfaces, as also 
conﬁrmed by the EDX spectra, where the peak of silver can be observed in both the luminal and 
outer surface (Fig. 2, arrows). The backscattered electrons emphasize the presence of silver, due to 
the visible contrast associated to the different chemical composition between substrate and coating. 
 
3.3. Silver ion release 
The results obtained by ICP-MS analysis are reported in Table 1. The average values of silver ion 
release ± standard deviation are reported as parts per millions (ppm) for each time point. 
 
3.4. Microbiological characterization 
3.4.1. Bacterial bioﬁlm growth on uncoated Foley catheter sections 
Analysis indicated that there was a signiﬁcant difference between the growth of Escherichia coli, 
Klebsiella pneumoniae and Proteus mirabilis on untreated catheter samples, at each of the time 
points, respectively (Fig. 3). Growth of Klebsiella pneumoniae was not observed on agar plates at day 
three, but colonies were observed at all subsequent time points. There was a statistically signiﬁcant 
difference in the growth proﬁle of each organism on the uncoated catheter sections (ANOVA, F = 
10.27, p = 0.005). Analysis  between each  time point for the  same bacterial strain on both treated 
and  untreated samples (Minitab(R), t- test,  p = 0.05)  revealed that the statistically signiﬁcant points 
were for E. coli: day 3 (p = 0.312), day 7 (p = 0.097), day 10 (p = 0.032), and  day  14 (p = 0.025); P. 
mirabilis: day  3 (p = 0.28),  day  7 (p = 
 
 
 
Fig. 1. SEM analysis of (a) untreated catheter, (b) external surface of the silver-treated catheter and 
(c) inner surface of the silver-treated catheter. 
  
  
 
Fig. 2. EDX analyses on sections of catheter samples on (a) untreated surface, (b) external silver 
treated surface and (c) inner silver treated surface. The arrows indicate the position of the silver 
peaks. 
 Table 1 
Average values obtained through ICP-MS analysis after incubation of silver treated catheters in 
artiﬁcial urine at different time points. 
Time points  Silver release (ppm) 
1 day   3.176 ± 0.016 
3 days   4.559 ± 0.067 
7 days   5.668 ± 0.053 
10 days  7.746 ± 0.043 
14 days  12.804 ± 0.146 
0.3), day 10 (p = 0.06), and day 14 (p = 0.003); and for K. pneumoniae: day 3 (p = 1.0), day 7 (p = 1.0), 
day 10 (p = 1.0), and day 14 (p =0.036). 
 
3.4.2. Bacterial bioﬁlm growth on coated Foley catheter sections 
There was a signiﬁcant difference between the growth of E. coli (p =0.192), K. pneumoniae (p = 
0.189) and P. mirabilis (p = 0.127) on treated catheter samples during the test period. No colonies of 
E. coli were observed at days  10 and  14; P. mirabilis  colonies were only observed once  at day 7; 
and  K. pneumoniae colonies only  observed at days  10 and  14, but  not  at days  3 and  7 (Fig. 4). At 
present, it is not  known whether the  reason for K. pneumoniae cells  not  being  recovered at days 3 
and 7 is due to poor adherence, or due to the efﬁcacy of the silver at the coating concentration. It is 
theorised to be due to poor adherence, as colonies were able to be recovered at later time points. 
This could be due to the expression of a thick capsule by this strain of K. pneumoniae adjusting the 
binding properties to the device, but further research is needed here to elucidate this point. 
 
3.4.3. Scanning electron microscopy of bacterial bioﬁlms 
A signiﬁcant amount of crystal formation was noted in almost all of the catheter sections. In general, 
however, deposition was less dense on the coated sections than the uncoated ones, for all three test 
species (K. pneumoniae, E. coli and P. mirabilis). The exact composition of the crystals is unknown.  It 
is likely to be struvite, but chemical testing would be required to verify this. Figs. 5 and 6 reveal 
bioﬁlm formation by K. pneumoniae days 3 and 10, respectively. The greater bioﬁlm formation was 
observed on untreated samples as opposed to treated ones. SEM micrographs indicate a much 
greater density of bacterial cells present on the untreated surface. Unlike the other two species, 
however, the number of K. pneumoniae cells decreased during the test period, correlating with the 
spread plate data.  The reduced adhesion of K. pneumoniae might be attributable to the expression 
of the capsule by this bacterial species. The importance of the capsule in the adherence of K. 
pneumoniae has been well documented. Indeed, this structure is perhaps recognized as the most 
important virulence factor of this bacterial species [25]. 
 
 
 
 
Fig. 3. The growth of Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis on untreated 
catheter samples. Error bars represent standard deviation from the mean data. 
  
   
Fig. 4. The growth of Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis on treated 
catheter samples. Error bars represent standard deviation from the mean data. 
 
4. Discussion 
CAUTIs have been recognized as the most important cause of nosocomial infections associated with 
increased morbidity and mortality [1]. Antibacterial urinary tract devices to prevent UTIs are in great 
demand [26], and several preventive measures have been attempted including antibiotics, 
antiseptics and silver coatings deposited on catheters [27–29]. Chlorhexidine-loaded nanospheres 
sprayed on silicone surfaces have been proposed as coating of ureteral devices for sustained 
antibacterial release [26]; the modiﬁcation of latex-based catheters by the deposition of MgF2 NPs 
has been analysed for prevention of bacterial colonisation and long-lasting self-sterilizing properties 
[30].  Also  antimicrobial-impregnated  catheters  coated  with minocycline and rifampicin have  
been reported as effective in reducing the  incidence of Gram  positive bacteriuria from  38% with 
non-coated catheters to 7% [31]. However, the near-universal use of antibiotics and the related risk 
of bacterial resistance have encouraged alternative approaches in prevention of catheter 
colonisation such as silver- and silver-coated hydrogel catheters [29, 31, and 32]. Catheters coated 
with silver alloy/hydrogel have been introduced into practice and a growing number of scientiﬁc 
works supports their use [29]. When compared with un- treated catheters, silver alloy catheters 
demonstrated signiﬁcantly reduced bacteriuria [28] and silver-hydrogel urinary catheters resulted in 
a 45% reduction in the incidence of catheter-associated UTIs [33]. In 
1997, the University of Massachusetts Medical Center introduced silver-hydrogel urinary catheters 
as a mean to reduce the incidence of catheter-associated UTIs; however, this reduction did not reach 
statistical signiﬁcance [33]. The hydrogel coating provides the catheter with the important 
advantage of low static and kinetic friction factors [23], which are of key importance to patient care. 
However, when deposited over the silver coating, the hydrogel may delay the activity of silver be- 
cause of reduced ion diffusion. The mechanism of antibacterial activity proposed is associated with 
an initial  inhibition of primary adherence due  to the  hydrogel hydrophilicity, followed by secondary 
biocidal activity  of the silver  coating [32,34]. 
Other methods have been described in literature, such as the Erlanger silver catheters developed by 
impregnating silicone and polyurethane with silver [35], as well as the modiﬁcation of catheters 
through immersion in biosynthesized AgNPs suspension [36]. The devices developed in this work 
utilises synthesised silver clusters, which are deposited simultaneously on the outer and the luminal 
surface of Foley catheters for prevention of UTIs. The technology, based on a photo- chemical 
reaction from a covalent silver precursor to metallic silver is characterized by some advantages, such 
as a long-term antimicrobial capability and the excellent adhesion of the coating to the substrate 
[37–39]. Moreover, the process can be easily adopted to deposit silver on different natural and 
synthetic substrates, thus suggesting a great potential of the technology in many biomedical 
applications. 
The work presented in this paper investigates the potential of photo- deposited silver coatings on 
silicone-coated latex urinary catheters, for reduced adhesion of key bacterial species linked to 
urinary tract infections. The ﬁrst part of the work was conducted to assess the efﬁcacy of the process 
to provide a homogeneous distribution of the particles on both the surfaces of the catheters. SEM-
EDX analyses conﬁrmed the success of this procedure, with the visible presence of silver particles on 
the substrate (Figs. 1 and 2). As expected, the presence of silver was lower onto the luminal surface 
than the outer, because of the lower intensity of UV radiation inside the device (Fig. 2). This effect 
was also assessed in a previous work, where the silver deposition was performed onto both the 
surfaces of haemodialysis polyurethane catheters. The amount of silver deposited resulted lower 
onto the inner surface, and the size of the particles deposited on the polymeric substrate was about 
100–120 nm [40]. 
 
  
Fig. 5. Scanning Electron Micrographs of Klebsiella pneumoniae cultured on (a) treated and (b) 
untreated catheter sections after 3 days in artiﬁcial urine medium at 37 °C. 
 
Several  approaches have  been used  to prevent earliest steps of bio- ﬁlm formation or to disrupt 
already formed bioﬁlms; antibiotics, heparin, silver  oxide  and  silver  alloys have  all been applied to 
the  catheter surface as preventive  measures [31,41,42]. Silicone is widely used as inert biomaterial 
for urinary devices [26]; however, silicone is more hydrophobic and rougher than acrylic and, thus 
presents a surface more easily able to be colonised by common human-associated microorganisms 
such as Staphylococcus epidermidis [43]. 
At the same time point’s deﬁned for microbiological characterization, the silver ion release from 
silver coated catheter in artiﬁcial urine was calculated. The results reported in Table 1 indicate low 
concentrations of silver   release ranging between 3.176   ± 0.016   and   12.804 ± 0.146 ppm over 
the experiment. The low concentration of silver ions calculated can be associated to limited 
spontaneous release of silver ions in contact with aqueous media, along with possible interactions of 
the released silver ions with components of the artiﬁcial urine. Further, microbiological analysis 
indicates that the treated catheter sections appear to reduce overall coverage/bioﬁlm mass on the 
catheter sections, compared with the untreated sections, when examined using SEM (Figs. 5 and 6). 
It must be noted that bacterial cells were not always visible on each catheter section. It is possible 
that the formation of what appear to be crystals on the surface is part of a bioﬁlm, and that the cells 
are contained beneath the surface of those crystals. In urinary tract infections, it is known that P. 
mirabilis, for example, forms crystal-like bioﬁlms which can contain live bacterial cells [44]. However, 
the crystals were not investigated further during this project, but could represent an appropriate 
avenue for future research. Analysis of the  growth proﬁles for each bacterial species over the 
fourteen day test period suggests  that while all three of the  test  species will develop into  bioﬁlms, 
the  treated surface is effective at reducing the  rate  of colonisation (Figs. 3 and  4). On the 
untreated catheters, data obtained both E. coli and P. mirabilis indicates that both species were able 
to form a bioﬁlm on the surface, which continued to increase in size throughout the test period. On 
the  treated surfaces, however, not  only  were the  sizes  of the  E. coli and  P. mirabilis  bioﬁlms 
signiﬁcantly smaller than those on the  untreated surfaces, the  presence of viable  cells of each  
species was undetectable after  7 days  incubation. In contrast, the presence of K. pneumoniae cells 
was only observed on days 10 and 14. This suggests that each species responded to the coating 
differently, despite all three species being closely related. This might be related to the capsule 
produced by K. pneumoniae, and increased long-term survival might relate to the upregulation of 
capsule-associated genes.  Whilst it was not measured within this study, the up- and down-
regulation of capsule-associated genes would represent an interesting direction for future research. 
 
  
 
 
  
 
Fig. 6. Scanning Electron Micrographs of Klebsiella pneumoniae cultured on (a) treated and (b) 
untreated catheter sections after 10 days in artiﬁcial urine medium at 37 °C. 
  
5. Conclusions 
Urinary tract infections have been recognized as one of the most common causes of morbidity and 
mortality, and represent a serious concern associated with the use of indwelling urinary catheters. 
The in- creasing resistance of microorganisms to conventional antimicrobial therapies, along  with 
high health-care costs, have  recently encouraged the  development of novel  routes towards non-
conventional strategies to prevent the risk of infections associated to biomedical devices [45]. 
In this work, novel antimicrobial silver coatings were deposited on urinary catheters. The silver 
deposition technology adopted is based on the in situ photo-chemical deposition of silver particles 
on the substrates and is characterized by nanometric size, excellent resistance even in biological 
environment and strong antibacterial and antifungal capability [46, 47].  The antibacterial silver 
treated catheters developed demonstrated good efﬁcacy against common microorganisms 
responsible for urinary infections, and could be suggested as an interesting strategy for infections 
prevention. 
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